{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:37:39Z","timestamp":1775975859056,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":7735,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[1985,8]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The concentration of free <jats:italic>myo<\/jats:italic>\u2010inositol in CSF was determined with a gas chromatographic\u2010mass spectrometric method using deuterated <jats:italic>myo<\/jats:italic>\u2010inositol as an internal standard after conversion to the hexa\u2010<jats:italic>O<\/jats:italic>\u2010acetyl derivative with acetic anhydride and pyridine. Twenty microliters of CSF is sufficient for the analysis which has a coefficient of variation of 9%. Identical analytical results were obtained on two different mass numbers. Schizophrenic patients were compared with healthy control persons. In addition, patients with rheumatoid arthritis or with neurological illnesses were studied. No consistent differences related to the illness could be found. The mean concentration of <jats:italic>myo<\/jats:italic>\u2010inositol was about 25 \u03bcg\/ml. Treatment of schizophrenic patients with chlorpromazine or sulpiride had no significant effect on the concentration of <jats:italic>myo<\/jats:italic>\u2010inositol in CSF.<\/jats:p>","DOI":"10.1111\/j.1471-4159.1985.tb03992.x","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T17:45:58Z","timestamp":1160070358000},"page":"331-334","source":"Crossref","is-referenced-by-count":13,"title":["Gas Chromatographic\u2010Mass Spectrometric Determination of <i>myo<\/i>\u2010Inositol in Human Cerebrospinal Fluid"],"prefix":"10.1111","volume":"45","author":[{"given":"Carl\u2010Gunnar","family":"Swahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/newbio233267a0"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200090402"},{"key":"e_1_2_2_4_1","first-page":"65","article-title":"Reduced myo\u2010inositol levels in cerebrospinal fluid from patients with affective disorders","volume":"13","author":"Barkai A. I.","year":"1978","journal-title":"Biol. Psychiatry"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00242834"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(83)90146-7"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.15.4.348"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb06856.x"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(08)60972-3"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6215(00)83319-4"},{"key":"e_1_2_2_11_1","first-page":"368","article-title":"Elevated myo\u2010inositol concentrations in cerebrospinal fluid of neonates and of patients with an impaired state of consciousness","volume":"25","author":"Lepkifker E.","year":"1976","journal-title":"Biomedicine (Express)"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1974.tb03183.x"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1955.sp005352"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200070708"},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1977.tb01416.x"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(77)90015-X"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.1985.tb03992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.1985.tb03992.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:05:12Z","timestamp":1697832312000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.1985.tb03992.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["10.1111\/j.1471-4159.1985.tb03992.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.1985.tb03992.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}